VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GHGuardant Health, Inc.
$162.92$21.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGHQuarterly Financials

Guardant Health, Inc. (GH) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Guardant Health, Inc. (GH) quarterly income statement — complete revenue, gross profit & net income history

GH Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue301.67M281.27M265.2M232.09M203.47M201.81M191.48M177.24M168.49M155.05M143.03M137.15M128.71M126.89M117.4M109.14M96.1M108.11M94.78M92.1M
Revenue Growth %48.26%39.37%38.5%30.95%20.76%30.16%33.87%29.23%30.9%22.19%21.83%25.66%33.94%17.37%23.87%18.5%22.16%38.04%27.1%38.84%
Cost of Goods Sold104.92M99.49M93.59M81.2M74.72M77.59M74.49M72.42M65.3M-81.14M57.61M53.85M53.07M47.12M40.5M36.73M31.98M33.42M30.82M29.93M
COGS % of Revenue34.78%35.37%35.29%34.99%36.72%38.45%38.9%40.86%38.75%-52.33%40.28%39.26%41.23%37.13%34.49%33.65%33.28%30.92%32.51%32.49%
Gross Profit196.75M181.77M171.61M150.88M128.75M124.22M116.99M104.81M103.19M236.19M85.42M83.3M75.64M79.77M76.91M72.42M64.12M74.69M63.96M62.17M
Gross Margin %65.22%64.63%64.71%65.01%63.28%61.55%61.1%59.14%61.25%152.33%59.72%60.74%58.77%62.87%65.51%66.35%66.72%69.08%67.49%67.51%
Gross Profit Growth %52.81%46.33%46.69%43.95%24.76%-47.41%36.96%25.82%36.43%196.09%11.06%15.03%17.97%6.81%20.24%16.47%28.45%49.64%19.82%41.63%
Operating Expenses318.1M302.58M270.6M257.3M239.79M250.19M234.31M205.43M202.88M433.7M198.96M202.92M209.7M225.89M221.51M202.74M187.46M172.89M171.25M159.82M
OpEx % of Revenue105.45%107.58%102.04%110.86%117.85%123.97%122.37%115.91%120.41%279.71%139.1%147.95%162.92%178.02%188.67%185.75%195.07%159.93%180.68%173.52%
Selling, General & Admin227.06M204.31M180.64M169.85M151.27M156.64M147.01M122.33M119.08M116.79M105.11M112.56M116.57M119.31M121.49M117.28M105.7M99.87M100.28M96.09M
SG&A % of Revenue75.27%72.64%68.12%73.18%74.34%77.62%76.78%69.02%70.67%75.32%73.49%82.07%90.56%94.03%103.48%107.46%109.99%92.38%105.81%104.33%
Research & Development91.04M98.26M89.96M87.45M88.52M93.54M87.31M83.1M83.8M89.86M93.85M90.36M93.13M106.58M100.02M85.45M81.76M73.02M70.97M63.72M
R&D % of Revenue30.18%34.94%33.92%37.68%43.51%46.35%45.6%46.89%49.74%57.95%65.62%65.88%72.35%83.99%85.19%78.3%85.08%67.54%74.88%69.19%
Other Operating Expenses0000000001000K000000-48K0-187K-243K
Operating Income-121.35M-120.81M-98.99M-106.41M-111.04M-125.97M-117.33M-100.62M-99.68M-197.51M-113.54M-119.62M-134.06M-146.12M-144.6M-130.32M-123.34M-98.21M-107.29M-97.64M
Operating Margin %-40.23%-42.95%-37.33%-45.85%-54.57%-62.42%-61.28%-56.77%-59.16%-127.38%-79.38%-87.22%-104.15%-115.15%-123.16%-119.4%-128.34%-90.84%-113.2%-106.02%
Operating Income Growth %-9.28%4.1%15.63%-5.76%-11.39%36.22%-3.33%15.88%25.64%-35.17%21.48%8.21%-8.69%-48.79%-34.78%-33.47%-14.35%-7.72%-44.49%-78.77%
EBITDA-111.91M-110.75M-89.58M-96.37M-100.81M-115.51M-106.73M-89.92M-88.97M-186.64M-102.51M-108.98M-123.71M-135.95M-134.79M-121.54M-116.14M-92.12M-101.79M-92.04M
EBITDA Margin %-37.1%-39.38%-33.78%-41.52%-49.54%-57.24%-55.74%-50.73%-52.8%-120.37%-71.67%-79.46%-96.11%-107.14%-114.81%-111.35%-120.85%-85.21%-107.4%-99.94%
EBITDA Growth %-11.01%4.12%16.07%-7.18%-13.3%38.11%-4.12%17.5%28.08%-37.29%23.95%10.33%-6.52%-47.58%-32.43%-32.04%-12.92%-6.42%-45.62%-88.13%
D&A (Non-Cash Add-back)9.44M10.05M9.41M10.04M10.24M10.45M10.6M10.7M10.71M10.87M11.04M10.63M10.35M10.17M9.81M8.79M7.2M6.09M5.5M5.6M
EBIT-110.36M-129.04M-91.65M-98.88M-94.08M-109.64M-107.08M-101.85M-113.94M-186.94M-84.97M-71.63M-132.65M-138.69M-161.24M-228.34M-122.61M-71.66M-106.79M-96.85M
Net Interest Income9.8M8.85M6.45M6.58M8.32M11.01M12.61M13.27M14.22M13.24M11.05M6.08M2.42M1.51M1.11M742K134K10K45K393K
Interest Income11.15M10.03M7.39M7.56M9.11M11.65M13.26M13.91M14.87M13.89M11.69M6.73M3.06M2.15M1.75M1.39M778K653K689K1.04M
Interest Expense1.35M1.18M943K983K791K645K646K645K645K645K644K645K644K644K644K645K644K643K644K644K
Other Income/Expense9.65M-9.42M6.4M6.55M16.17M15.68M9.6M-1.88M-14.9M9.93M27.93M47.34M762K6.79M-17.28M-98.67M86K25.91M-142K150K
Pretax Income-111.7M-130.22M-92.59M-99.86M-94.87M-110.29M-107.72M-102.5M-114.58M-187.58M-85.61M-72.28M-133.29M-139.33M-161.88M-228.99M-123.25M-72.3M-107.43M-97.49M
Pretax Margin %-37.03%-46.3%-34.91%-43.03%-46.63%-54.65%-56.26%-57.83%-68%-120.98%-59.86%-52.7%-103.56%-109.8%-137.88%-209.8%-128.26%-66.88%-113.35%-105.85%
Income Tax372K-1.73M136K38K290K716K30K133K405K-541K490K496K240K602K115K446K-24K11K96K83K
Effective Tax Rate %-0.33%1.33%-0.15%-0.04%-0.31%-0.65%-0.03%-0.13%-0.35%0.29%-0.57%-0.69%-0.18%-0.43%-0.07%-0.19%0.02%-0.02%-0.09%-0.09%
Net Income-112.08M-128.49M-92.72M-99.9M-95.16M-111.01M-107.75M-102.63M-114.98M-187.04M-86.1M-72.77M-133.53M-139.93M-161.99M-229.43M-123.23M-90.91M-107.53M-97.58M
Net Margin %-37.15%-45.68%-34.96%-43.04%-46.77%-55%-56.28%-57.9%-68.24%-120.63%-60.2%-53.06%-103.74%-110.28%-137.98%-210.21%-128.23%-84.09%-113.45%-105.94%
Net Income Growth %-17.78%-15.75%13.95%2.66%17.24%40.65%-25.15%-41.03%13.89%-33.67%46.85%68.28%-8.36%-53.92%-50.66%-135.13%-12.37%3.02%-38.44%-78.58%
Net Income (Continuing)-112.08M-128.49M-92.72M-99.9M-95.16M-111.01M-107.75M-102.63M-114.98M-187.04M-86.1M-72.77M-133.53M-139.93M-161.99M-229.43M-123.23M-72.31M-107.53M-97.58M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000059.4M59.4M
EPS (Diluted)-0.85-1.00-0.74-0.80-0.77-0.90-0.88-0.84-0.94-1.58-0.73-0.67-1.30-1.36-1.58-2.25-1.21-0.89-1.06-0.96
EPS Growth %-10.39%-11.11%15.91%4.76%18.09%43.04%-20.55%-25.37%27.69%-16.18%53.8%70.22%-7.44%-52.81%-49.06%-134.38%-11.01%5.32%-35.9%-68.42%
EPS (Basic)-0.85-1.00-0.74-0.80-0.77-0.90-0.88-0.84-0.94-1.58-0.73-0.67-1.30-1.36-1.58-2.25-1.21-0.89-1.06-0.96
Diluted Shares Outstanding131.27M128.66M125.3M124.11M123.87M123.75M123.05M122.45M121.71M118.51M117.74M108.81M102.66M102.52M102.29M102.05M101.85M101.7M101.42M101.17M
Basic Shares Outstanding131.27M128.66M124.81M124.11M123.87M123.75M123.05M122.45M121.71M118.51M117.74M108.81M102.66M102.52M102.29M102.05M101.85M101.7M101.42M101.17M
Dividend Payout Ratio--------------------